Vestibular Balance-Cognition Dual-Task Digital System: Development of a Smart Rehabilitation Platform for the Elderly and Prediction of Balance Function Risks
Studieoversikt
Status
Status
Forhold
Forhold
Intervensjon / Behandling
Intervensjon / Behandling
Studietype
Studietype
Registrering (Antatt)
Registrering
Kontakter og plasseringer
Studiekontakt
Studiekontakt
- Navn: Po-Yin Chen, PhD
- Telefonnummer: 67166 +886-2-2826-7000
- E-post: poyin1128@nycu.edu.tw
Studer Kontakt Backup
- Navn: Quan-Chen Wu, MS
- Telefonnummer: 65925 +886-2-2826-7000
- E-post: kc1211.be14@nycu.edu.tw
Studiesteder
-
-
Taipei
-
Taipei, Taipei, Taiwan, 112
- Rekruttering
- National Yang Ming Chiao Tung University, Department of Physical Therapy and Assistive Technology
-
Ta kontakt med:
- Po-Yin Chen, Assistant Professor, PhD
- Telefonnummer: 67166 +886-2-2826-7000
- E-post: poyin1128@nycu.edu.tw
-
Ta kontakt med:
- Quan-Chen Wu, Research Assistant, MS
- Telefonnummer: 65925 +886-2-2826-7000
- E-post: kc1211.be14@nycu.edu.tw
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Voksen
- Eldre voksen
Tar imot friske frivillige
Prøvetakingsmetode
Studiepopulasjon
Beskrivelse
Inclusion Criteria:
- Community-dwelling adults aged 55 years or older.
- Able to walk at least 30 meters independently or with the use of a walking aid.
- Able to understand the study procedures and communicate in Mandarin or Taiwanese.
- Adequate corrected vision to go out independently.
- Able to participate in 45-minute sessions of moderate-intensity exercise once per week.
Exclusion Criteria:
- Severe central or peripheral neurological diseases.
- Blindness or deafness.
- Inability to communicate verbally or to understand simple instructions.
- Current fractures or major joint injuries.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
Antall grupper / kohorter
Kohorter og intervensjoner
Gruppe / KohortGruppe / Kohort |
Intervensjon / BehandlingIntervensjon / Behandling |
|---|---|
|
Healthy Older Adults
Community-dwelling older adults aged 55 years and older who are able to walk at least 30 meters independently or with a walking aid, can communicate in Mandarin or Taiwanese, have adequate corrected vision to go out independently, and can participate in 45-minute sessions of moderate-intensity exercise once per week.
Individuals with severe central or peripheral neurological diseases, blindness or deafness, inability to communicate verbally or understand instructions, or current fractures or major joint injuries will be excluded.
|
Participants undergo a series of static and dynamic balance and gait assessments in a motion analysis laboratory while wearing body-segment inertial measurement units (IMUs).
The sensors provide real-time signals for interaction with the evaluation system during single-task and dual-task standing and walking tests.
Participants complete a battery of self-report questionnaires and paper-based cognitive tests after explanation by a physical therapist.
Instruments include dizziness and balance scales, the Activities-specific Balance Confidence (ABC) scale, and cognitive tests such as the WAIS-III Taiwan Digit Odd-Even Sequencing Test, Taiwan Stroop Word-Color Test, path judgment tasks, and mental rotation tasks.
Questionnaires are administered verbally and responses recorded in writing.
|
Hva måler studien?
Primære resultatmål
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Gait speed
Tidsramme: Baseline laboratory assessment (single visit in year 1)
|
Average forward velocity of whole-body progression during walking, calculated as total distance divided by time.
|
Baseline laboratory assessment (single visit in year 1)
|
|
Stride length (m)
Tidsramme: Baseline laboratory assessment (single visit in year 1)
|
Linear distance between two consecutive initial contacts of the same foot.
|
Baseline laboratory assessment (single visit in year 1)
|
|
Step width (m)
Tidsramme: Baseline laboratory assessment (single visit in year 1)
|
Mediolateral distance between consecutive foot placements, representing base of support during gait.
|
Baseline laboratory assessment (single visit in year 1)
|
|
Cadence (steps/min)
Tidsramme: Baseline laboratory assessment (single visit in year 1)
|
Number of steps taken per minute during walking.
|
Baseline laboratory assessment (single visit in year 1)
|
|
Step-to-step variability (%)
Tidsramme: Baseline laboratory assessment (single visit in year 1)
|
Variability of consecutive steps, typically quantified as the coefficient of variation of stride time or step length.
|
Baseline laboratory assessment (single visit in year 1)
|
|
Trunk angular velocity (degrees/s)
Tidsramme: Baseline laboratory assessment (single visit in year 1)
|
Rate of change in trunk segment orientation over time, derived from rotational kinematics.
|
Baseline laboratory assessment (single visit in year 1)
|
|
Trunk angular displacement (degrees)
Tidsramme: Baseline laboratory assessment (single visit in year 1)
|
Magnitude of trunk segment rotation relative to a reference orientation.
|
Baseline laboratory assessment (single visit in year 1)
|
|
Center-of-mass displacement (m)
Tidsramme: Baseline laboratory assessment (single visit in year 1)
|
Spatial excursion of the body's center of mass, typically analyzed in anterior-posterior and mediolateral directions during standing.
|
Baseline laboratory assessment (single visit in year 1)
|
|
Response time (s or ms)
Tidsramme: Baseline laboratory assessment (single visit in year 1)
|
Time elapsed between stimulus onset and initiation of a motor response.
|
Baseline laboratory assessment (single visit in year 1)
|
Sekundære resultatmål
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Montreal Cognitive Assessment-Taiwan version score (0-30points)
Tidsramme: Baseline laboratory assessment
|
Total score on the Montreal Cognitive Assessment-Taiwan version, representing global cognitive function.
|
Baseline laboratory assessment
|
|
Path tracing completion time (s)
Tidsramme: Baseline laboratory assessment
|
Time required to complete the Color Trails Test-1 task.
|
Baseline laboratory assessment
|
|
Stroop test score (count as PR1-99%)
Tidsramme: Baseline laboratory assessment
|
Score of Stroop-type task, indicating inhibitory control and selective attention.
|
Baseline laboratory assessment
|
|
Working memory completion time (s)
Tidsramme: Baseline laboratory assessment
|
Time required to complete the Color Trails Test-2 task.
|
Baseline laboratory assessment
|
|
Mental rotation accuracy (number of correct responses)(0-16)
Tidsramme: Baseline laboratory assessment
|
Number of correct responses in the mental rotation task, reflecting visuospatial processing ability.
|
Baseline laboratory assessment
|
|
Mental rotation completion time (s)
Tidsramme: Baseline laboratory assessment
|
Time required to complete the mental rotation task.
|
Baseline laboratory assessment
|
|
Activities-specific Balance Confidence score (0-100 points)
Tidsramme: Baseline laboratory assessment
|
Total score on the Activities-specific Balance Confidence (ABC) scale, reflecting perceived balance confidence during daily activities; higher scores indicate greater confidence.
|
Baseline laboratory assessment
|
|
Dizziness Handicap Inventory score (0-100points)
Tidsramme: Baseline laboratory assessment
|
Total score on the Dizziness Handicap Inventory (DHI), representing self-perceived handicap due to dizziness; higher scores indicate greater disability.
|
Baseline laboratory assessment
|
|
Hospital Anxiety and Depression Scale - Anxiety score (0-21 points)
Tidsramme: Baseline laboratory assessment
|
Subscale score of the HADS assessing anxiety symptoms; higher scores indicate greater anxiety.
|
Baseline laboratory assessment
|
|
Hospital Anxiety and Depression Scale - Depression score (0-21 points)
Tidsramme: Baseline laboratory assessment
|
Subscale score of the HADS assessing depressive symptoms; higher scores indicate greater depression.
|
Baseline laboratory assessment
|
|
Visual Vertigo Analogue Scale score ( 0-90points)
Tidsramme: Baseline laboratory assessment
|
Self-reported severity of visually induced dizziness measured using a visual analogue scale; higher scores indicate greater symptom severity.
|
Baseline laboratory assessment
|
|
Dynamic Gait Index score (0-24 points)
Tidsramme: Baseline laboratory assessment
|
Total score on the Dynamic Gait Index, based on performance across eight functional gait tasks; lower scores indicate poorer gait performance and increased fall risk.
|
Baseline laboratory assessment
|
|
Tinetti total score (0-28 points)
Tidsramme: Baseline laboratory assessment
|
Combined score of balance and gait subscales in the Tinetti assessment; lower scores indicate higher overall fall risk.
|
Baseline laboratory assessment
|
Samarbeidspartnere og etterforskere
Sponsor
Sponsor
Etterforskere
Etterforskere
- Hovedetterforsker: Po-Yin Chen, PhD, National Yang Ming Chiao Tung University, Department of Physical Therapy and Assistive Technology
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Studiestart
Primær fullføring (Antatt)
Primær fullføring
Studiet fullført (Antatt)
Studiet fullført
Datoer for studieregistrering
Først innsendt
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Først lagt ut
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Sist oppdatering lagt ut
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
- Nevrologiske manifestasjoner
- Sensasjonsforstyrrelser
- Patologiske tilstander, tegn og symptomer
- Tegn og symptomer
- Svimmelhet
- Helsevesenets kvalitet, tilgang og evaluering
- Undersøkelsesteknikker
- Epidemiologiske metoder
- Datainnsamling
- Helsevesenets evalueringsmekanismer
- Kvalitet på helsehjelpen
- Folkehelse
- Miljø og folkehelse
- Undersøkelser og spørreskjemaer
Andre studie-ID-numre
Andre studie-ID-numre
- NYCU114022AF
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
IPD-planbeskrivelse
IPD-delingstidsramme
Tilgangskriterier for IPD-deling
IPD-deling Støtteinformasjonstype
- STUDY_PROTOCOL
- SEVJE
- ANALYTIC_CODE
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .